Sex steroids and bone metabolism: Comparison of in vitro effects of 17β-estradiol and testosterone on human osteosarcoma cell lines of various gender and differentiation

Summary:

Although numerous clinical studies have demonstrated the beneficial effect of preventing postmenopausal bone loss in elder women by long-term estrogen administration, effects of estrogen at the cellular level still remain unclear. Efforts to determine the precise role of bone cells in estrogen-mediated pathways are often hampered by the lack of suitable cell culture models. Presuming that sex steroids have a direct, stimulating effect on bone cells in vitro, we investigated the influence of 17β-estradiol, testosterone and 1,25(OH)₂D₃ on cell proliferation and differentiation using four established human osteosarcoma (HOS) cell lines of different gender of the donors (male origin: MG 63, HOS 58; female origin: SaOS 2, TE 85). These cell lines are believed to represent different stages of osteogenic maturation. Thus, the aim of this study was to clarify if possible responses to sex steroids are related to gender or osteogenic commitment of the individual cell culture. HOS cells were cultured in six-well plates and underwent hormone treatment (1 nM and 10 nM 17β-estradiol, 0.1 nM and 1 nM testosterone and 1 μM 1,25(OH)₂D₃) for 48 h hours. Cell proliferation was determined by measuring total cell numbers. Cell function was studied by measuring alkaline phosphatase activity and secreted osteocalcin. In this study, estrogen significantly increased proliferation of both one male (MG 63) and one female (SaOS 2) cell line, but decreased proliferation of the female HOS TE 85 cell line significantly. Testosterone treatment had a positive effect on proliferation of only one female cell line (SaOS 2). A significant increase of alkaline phosphatase activity in SaOS 2 and HOS 58 cells and of osteocalcin levels in SaOS 2 cells was detected following estrogen treatment. Administration of 1,25(OH)₂D₃ was followed by an increased cell proliferation in HOS 58, MG 63 and SaOS 2. Significant gender-related differences could not be demonstrated. In conclusion, response to hormonal treatment with sex steroids is not related to the gender of the osteosarcoma cell line, but rather depends on its osteoblastic commitment.

Bone cells - osteosarcoma - differentiation - estrogen - testosterone - menopause

References

• 1 Abu E O, Horner A, Kusec V, Triffitt J T, Compston J E. The localization of androgen receptors in human bone.  J Clin Endocrinol Metab. 82 3493-3497 1997; 
• 2 Albright F, Reifenstein C. The parathyroid glands and metabolic bone disease. Baltimore: Williams and Wilkens Company 1948
• 3 Auf'mkolk B, Hauschka P V, Schwartz E R. Characterization of human bone cells in culture.  Calcif Tissue Int. 37 228-235 1985; 
• 4 Bain S D, Bailey M C, Celino D L, Lantry M M, Edwards M W. High-dose estrogen inhibits bone resorption and stimulates bone formation in the ovariectomized mouse.  J Bone Miner Res. 8 435-442 1993; 
• 5 Beresford J N, Gallagher J A, Russell R G. 1,25-Dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation.  Endocrinology. 119 1776-1785 1986; 
• 6 Bergmeyer H U, Büttner H, Hillmann G, Kreutz F H, Lang H, Laune D, Rick W, Schmidt E, Schmidt F W, Stamm D, Szasz G. Empfehlungen der Deutschen Gesellschaft für Klinische Chemie. Standardisierung von Methoden zur Bestimmung von Enzymaktivitäten in biologischen Flüssigkeiten.  Z klin Chem u klin Biochem. 8 658-660 1970; 
• 7 Berson S A, Yalow R S. General principles of radioimmunoassay.  Clin Chim Acta. 22 51-69 1968; 
• 8 Bonewald L F, Kester M B, Schwartz Z, Swain L D, Khare A, Johnson T L, Leach R J, Boyan B D. Effects of combining transforming growth factor beta and 1,25 dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63).  J Biol Chem. 267 8943-8949 1992; 
• 9 Bronckers A L, Gay S, Dimuzio M T, Butler W T. Immunolocalization of gamma-carboxyglutamic acid containing proteins in developing rat bones.  Coll Relat Res. 5 273-281 1985; 
• 10 Bruch H R, Wolf L, Budde R, Romalo G, Schweikert H U. Androstenedione metabolism in cultured human osteoblast-like cells.  J Clin Endocrinol Metab. 75 101-105 1992; 
• 11 Canalis E, Raisz L G. Effect of sex steroids on bone collagen synthesis in vitro.  Calcif Tissue Res. 25 105-110 1978; 
• 12 Caputo C B, Meadows D, Raisz L G. Failure of estrogens and androgens to inhibit bone resorption in tissue culture.  Endocrinology. 98 1065-1068 1976; 
• 13 Chaudhary L R, Spelsberg T C, Riggs B L. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17β estradiol.  Endocrinology. 130 2528-2534 1992; 
• 14 Clover J, Gowen M. Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype?.  Bone. 15 585-591 1994; 
• 15 Colvard D S, Eriksen E F, Keeting P E, Wilson E M, Lubahn D B, French F S, Riggs B L, Spelsberg T C. Identification of androgen receptors in normal human osteoblast-like cells.  Proc Natl Acad Sci. 86 854-857 1989; 
• 16 Davis V L, Couse J F, Gray T K, Korach K S. Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines.  J Bone Miner Res. 9 983-991 1994; 
• 17 Eriksen E F, Colvard D S, Berg N J, Graham M L, Mann K G, Spelsberg T C, Riggs B L. Evidence of estrogen receptors in normal human osteoblast-like cells.  Science. 241 84-86 1988; 
• 18 Ernst M, Heath J K, Rodan G A. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones.  Endocrinology. 125 825-833 1989; 
• 19 Ernst M, Heath J K, Schmid C, Froesch R E, Rodan G A. Evidence for a direct effect of estrogen on bone cells in vitro.  J Steroid Biochem. 34 279-284 1989; 
• 20 Ernst M, Schmid C, Froesch E R. Enhanced osteoblast proliferation and collagen gene expression by estradiol.  Proc Natl Acad Sci. 85 2307-2310 1988; 
• 21 Etienne M C, Fischel J L, Milano G, Formento P, Formento J L, Francoual M, Frenay M, Namer M. Steroid receptors in human osteoblast-like cells.  Eur J Cancer. 26 807-810 1990; 
• 22 Eyre L J, Bland R, Bujalska I J, Sheppard M C, Stewart P M, Hewison M. Characterization of aromatase and 17 beta-hydroxysteroid dehydrogenase expression in rat osteoblastic cells.  J Bone Miner Res. 13 996-1004 1998; 
• 23 Felson D T, Zhang Y, Hannan M T, Kiel D P, Wilson P W, Anderson J J. The effect of postmenopausal estrogen therapy on bone density in elderly women.  N Engl J Med. 329 1141-1146 1993; 
• 24 Fogh J, Trempe G. Human Tumor Cell Lines in vitro: New human tumor cell lines. Fogh J (ed.) New York: Plenum Press 115-159 1975
• 25 Fukayama S, Tashjian A H. Direct modulation by androgens of the response of human bone cells (SaOS 2) to human parathyroid hormone (PTH) and PTH-related protein.  Endocrinology. 125 1789-1794 1989; 
• 26 Gray T K, Flynn T C, Gray K M, Nabell L M. Beta-estradiol acts directly on the clonal osteoblastic cell line UMR106.  Proc Natl Acad Sci. 84 6267-6271 1987; 
• 27 Gundle R, Beresford J N. The isolation and culture of cells from explants of human trabecular bone.  Calcif Tissue Int 56 ((Suppl 1)) 8-10 1995; 
• 28 Harris M. Growth measurements on monolayer cultures with an electronic cell counter.  Cancer Research. 19 1020-1024 1959; 
• 29 Heaney R P, Recker R R, Saville P D. Menopausal changes in bone remodeling.  J Lab Clin Med. 92 964-970 1978; 
• 30 Heremans H, Billiau A, Cassiman J J, Mulier J C, de Somer P. In vitro cultivation of human tumor tissues. II. Morphological and virological characterization of three cell lines.  Oncology. 35 246-252 1978; 
• 31 Ikegami A, Inoue S, Hosoi T, Mizuno Y, Nakamura T, Ouchi Y, Orimo H. Immunohistochemical detection and northern blot analysis of estrogen receptor in osteoblastic cells.  J Bone Miner Res. 8 1103-1109 1993; 
• 32 Jakob F, Siggelkow H, Homann D, Kohrle J, Adamski J, Schutze N. Local estradiol metabolism in osteoblast- and osteoclast-like cells.  J Steroid Biochem Mol Biol. 61 167-174 1997; 
• 33 Kasperk C H, Wergedal J E, Farley J R, Linkhart T A, Turner R T, Baylink D J. Androgens directly stimulate proliferation of bone cells in vitro.  Endocrinology. 124 1576-1578 1989; 
• 34 Kasperk C H, Ziegler R. Androgene und Knochenstoffwechsel. Bedeutung für die Osteoporose bei Mann und Frau.  Dtsch Med Wochenschr. 117 990-996 1992; 
• 35 Kassem M. Cellular and molecular effects of growth hormone and estrogen on human bone cells.  APMIS Suppl. 71 1-30 1997; 
• 36 Kaye A M, Weisman Y, Harell A, Somjen D. Hormonal stimulation of bone cell proliferation.  J Steroid Biochem Mol Biol. 37 431-435 1990; 
• 37 Keeting P E, Scott R E, Colvard D S, Han I K, Spelsberg T C, Riggs B L. Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells.  J Bone Miner Res. 6 297-304 1991; 
• 38 Kern A, Jundt G, Vonderheid B, Groscurth P, Schulz A. Establishment and functional characterization of a human osteosarcoma cell-line (HOS 58).  Calcif Tissue Int 46 ((Suppl 2)) 208 1990; 
• 39 Komm B S, Terpening C M, Benz D J, Graeme K A, Gallegos A, Korc M, Greene G L, O'Malley B W, Haussler M R. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.  Science. 241 81-84 1988; 
• 40 Kuznetsov S A, Krebsbach P H, Kazuhito S, Kerr J, Riminucci M, Benayahu D, Gehron Robey P. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo.  J Bone Miner Res. 12 1335-1347 1997; 
• 41 Kyeyune-Nyombi E, Lau K H, Baylink D J, Strong D D. 1,25 Dihydroxyvitamin D3 stimulates both alkaline phosphatase gene transcription and mRNA stability in human bone cells.  Arch Biochem Biophys. 291 316-325 1991; 
• 42 Lajeunesse D. Effect of 17 beta-estradiol on the human osteosarcoma cell line MG-63.  Bone Miner. 24 1-16 1994; 
• 43 Mahonen A, Maenpaa P H. Steroid hormone modulation of vitamin D receptor levels in human MG-63 osteosarcoma cells.  Biochem Biophys Res Commun. 205 1179-1186 1994; 
• 44 Mahonen A, Pirskanen A, Keinanen R, Maenpaa P H. Effect of 1,25(OH)2D3 on its receptor mRNA levels and osteocalcin synthesis in human osteosarcoma cells.  Biochim Biophys Acta. 1048 30-37 1990; 
• 45 Majeska R J, Ryaby J T, Einhorn T A. Direct modulation of osteoblastic activity with estrogen.  J Bone Joint Surg Am. 76 713-721 1994; 
• 46 McAllister R M, Gardner M B, Greene A E, Bradt C, Nichols W W, Landing B H. Cultivation in vitro of cells derived from a human osteosarcoma.  Cancer. 27 397-402 1971; 
• 47 Moore M, Bracker M, Sartoris D, Saltman P, Strause L. Long-term estrogen replacement therapy in postmenopausal women sustains vertebral bone mineral density.  J Bone Miner Res. 5 659-664 1990; 
• 48 Mora S, Weber G, Guarneri M P, Nizzoli G, Pasolini D, Chiumello G. Effect of estrogen replacement therapy on bone mineral content in girls with Turner syndrome.  Obstet Gynecol. 79 747-751 1992; 
• 49 Nakano Y, Morimoto I, Ishida O, Fujihira T, Mizokami A, Tanimoto A, Yanagihara N, Izumi F, Eto S. The receptor, metabolism and effects of androgen in osteoblastic MC3T3-E1 cells.  Bone Miner. 26 245-259 1994; 
• 50 Nijweide P J, Burger E H, Feyen J H. Cells of bone: proliferation, differentiation, and hormonal regulation.  Physiol Rev. 66 855-886 1986; 
• 51 Orwoll E S, Stribrska L, Ramsey E E, Keenan E J. Androgen receptors in osteoblast like cell lines.  Calcif Tissue Int. 49 183-187 1991; 
• 52 Owen M. Marrow stromal stem cells.  J Cell Sci Suppl. 10 63-76 1987; 
• 53 Peck W A, Birge S J, Fedak S A. Bone cells: Biochemical and biological studies after enzymatic isolation.  Science. 146 1476-1477 1964; 
• 54 Pfeilschifter J, Erdmann J, Schmidt W, Naumann A, Minne H W, Ziegler R. Differential regulation of plasminogen activator and plasminogen activator inhibitor by osteotropic factors in primary cultures of mature osteoblasts and osteoblast precursors.  Endocrinology. 126 703-711 1990; 
• 55 Pirskanen A, Jaaskelainen T, Maenpaa P H. Insulin-like growth factor-1 modulates steroid hormone effects on osteocalcin synthesis in human MG-63 osteosarcoma cells.  Eur J Biochem. 218 883-891 1993; 
• 56 Robey P G, Termine J D. Human bone cells in vitro.  Calcif Tissue Int. 37 453-460 1985; 
• 57 Robinson J A, Harris S A, Riggs B L, Spelsberg T C. Estrogen regulation of human osteoblastic cell proliferation and differentiation.  Endocrinology. 138 2919-2927 1997; 
• 58 Robinson J A, Waters K M, Turner R T, Spelsberg T C. Direct action of naturally occurring estrogen metabolites on human osteoblastic cells.  J Bone Miner Res. 15 499-506 2000; 
• 59 Rodan S B, Imai Y, Thiede M A, Wesolowski G, Thompson D, Bar Shavit Z, Shull S, Mann K, Rodan G A. Characterization of a human osteosarcoma cell line (SaOS 2) with osteoblastic properties.  Cancer Res. 47 4961-4966 1987; 
• 60 Sands R, Studd J. Exogenous androgens in postmenopausal women.  Am J Med. 98 76S-79S 1985; 
• 61 Scharla S H, Minne H W, Waibel-Treber S, Schaible A, Lempert U G, Wüster C, Leyendecker G, Ziegler R. Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3.  J Clin Endocrinol Metab. 70 1055-1061 1990; 
• 62 Scheven B A, Damen C A, Hamilton N J, Verhaar H J, Duursma S A. Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro.  Biochem Biophys Res Commun. 186 54-60 1992; 
• 63 Schmidt R, Kulbe K D. Long-term cultivation of human osteoblasts.  Bone Miner. 20 211-221 1993; 
• 64 Shimodaira K, Fujikawa H, Okura F, Shimizu Y, Saito H, Yanaihara T. Osteoblast cells (MG-63 and HOS) have aromatase and 5 alpha-reductase activities.  Biochem Mol Biol Int. 39 109-116 1996; 
• 65 Siggelkow H, Niedhart C, Kurre W, Ihbe A, Schulz A, Atkinson M J, Hufner M. In vitro differentiation potential of a new human osteosarcoma cell line (HOS 58).  Differentiation. 63 81-91 1998; 
• 66 Slootweg M C, Ederveen A G, Schot L P, Schoonen W G, Kloosterboer H J. Estrogen and progestogen synergistically stimulate human and rat osteoblast proliferation.  J Endocrinol. 133 5-8 1992; 
• 67 Stepan J J, Lachman M, Zverina J, Pacovsky V, Baylink D J. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling.  J Clin Endocrinol Metab. 69 523-527 1989; 
• 68 Sutherland M K, Hui D U, Rao L G, Wylie J N, Murray T M. Immunohistochemical localization of the estrogen receptor in human osteoblastic SaOS 2 cells: association of receptor levels with alkaline phosphatase activity.  Bone. 18 361-369 1996; 
• 69 Tanaka S, Haji M, Nishi Y, Yanase T, Takayanagi R, Nawata H. Aromatase activity in human osteoblast-like osteosarcoma cell.  Calcif Tissue Int. 52 107-109 1993; 
• 70 Turksen K, Aubin J E. Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells.  J Cell Biol. 114 373-384 1991; 
• 71 Turner R T, Riggs B L, Spelsberg T C. Skeletal Effects of Estrogen.  Endocrine Reviews. 15 275-300 1994; 
• 72 Vanderschueren D, Bouillon R. Androgens and bone.  Calcif Tissue Int. 56 341-346 1995; 
• 73 Vanderschueren D, Van Herck E, Suiker A M, Visser W J, Schot L P, Bouillon R. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency.  Endocrinology. 130 2906-2916 1992; 
• 74 Verhaar H J, Damen C A, Duursma S A, Scheven B A. A comparison of the action of progestins and estrogen on the growth and differentiation of normal adult human osteoblast-like cells in vitro.  Bone. 15 307-311 1994;